Edition:
United States

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.24USD
18 Jan 2019
Change (% chg)

$0.09 (+2.86%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.32
Day's Low
$3.09
Volume
87,135
Avg. Vol
126,686
52-wk High
$8.55
52-wk Low
$2.62

Chart for

About

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related... (more)

Overall

Beta: 3.88
Market Cap(Mil.): $222.55
Shares Outstanding(Mil.): 62.87
Dividend: --
Yield (%): --

Financials

  ADVM.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.04 -- --
ROI: -30.46 0.60 13.80
ROE: -31.07 -2.18 15.29

Earnings vs. Estimates